SAN ANTONIO – The U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device. That decision is expected to significantly drive up demand for the San Antonio-based company’s germ-zapping robots. The Xenex machines utilize high-intensity, broad-spectrum ultraviolet light to reduce potentially deadly…Read More
Related Posts
Palisade Bio Inc Appoint JD Finley as CEO By Investingcom
Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade" or the "Company"), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that J.D. Finley has been named Chief…
Smoke Evacuation Systems Market Revenue to Cross USD 2988 million by 2031 Garnering 66 CAGR…
Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The smoke evacuation systems market was estimated to have acquired US$ 158.5 million in 2021.…
BD Names Greg Rodetis as Senior Vice President of Investor Relations
FRANKLIN LAKES, N.J., Oct. 17, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Greg Rodetis, currently BD senior vice president…
